NDATOPICALCREAM
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
0/100
Mechanism of Action
Janus Kinase Inhibitors
Pharmacologic Class:
Janus Kinase Inhibitor
Loss of Exclusivity
LOE Date
Sep 19, 2031
67 months away
Patent Expiry
Sep 19, 2031
Exclusivity Expiry
Jul 23, 2030
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 8609647 | Sep 19, 2031 | SubstanceProduct | U-4237 |
Company
Leo Pharma
Denmark - Ballerup